Location History:
- Lucknow, IN (2002)
- Uttar Pradesh, IN (2008 - 2011)
Company Filing History:
3 out of 2,096 
1 out of 832,891 Years Active: 2002-2011
Title: Anil Srivastava: Innovator in Anti-Tubercular Research
Introduction
Anil Srivastava is a notable inventor based in Uttar Pradesh, India. He has made significant contributions to the field of anti-tubercular research, holding a total of 4 patents. His work focuses on enhancing the effectiveness of treatments for tuberculosis, a disease that continues to pose a global health challenge.
Latest Patents
Anil Srivastava's latest patents include innovative methods for enhancing the anti-tubercular activity of active fractions isolated from various sources. One of his inventions discloses the non-toxic nature of a specific fraction, identifying sucrose as its main constituent. Interestingly, pure sucrose has been shown to lack anti-tubercular activity, indicating that the active properties reside in one or more minor constituents. These minor constituents are characterized as relatively low molecular weight entities, and Srivastava has developed a chromatographic technique for their separation to further investigate their activities and structures. Another significant patent involves herbal extracts from Salicornia species, which demonstrate antitubercular activity. This invention outlines a process for preparing novel extracts with potential therapeutic applications against tuberculosis.
Career Highlights
Anil Srivastava has worked with the Council of Scientific and Industrial Research, contributing to various research initiatives aimed at combating tuberculosis. His dedication to scientific inquiry and innovation has positioned him as a key figure in his field.
Collaborations
Throughout his career, Anil has collaborated with esteemed colleagues such as Yogendra Nath Shukla and Suman Preet Singh Khanuja. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Anil Srivastava's contributions to anti-tubercular research through his patents and collaborations highlight his commitment to addressing significant health challenges. His innovative approaches continue to pave the way for advancements in tuberculosis treatment.